Member Info for draft

Can't be bothered to wait

Loads people must have got spiked Wait 6-12, months, this will have a huge rise

It's my buy Expecting another big rise in this within 6-12 months

Reduced debt

Triple mcap received in cash funding

he Swiss life sciences supplier’s pharma & biotech segment saw revenue increased 15.9% in 2016 to CHF1.85bn ($1.84bn) with core earning growing 40.8% to CHF400m. Lonza said the gains were driven by strong momentum in its mammalian manufacturing business – which produces biopharmaceuticals for drug industry customers - and a “by a significant upward trend in all other technologies and modalities.” The firm also highlighted manufacturing contracts with Kodiak Sciences, bluebird bio and Clovis Oncology signed during the year. Company-wide revenues increased 8.7% to CHF4.13bn while earning grew 24.2% to CHF651m. Lonza will hold its conference call later today.

http://mobile.biopharma-reporter.com/Markets-Regulations/Biopharma-business-a-key-driver-for-Lonza-in-2016

Record profit announcement by lonza today

Take a look at lonzas performance

We will beat last year

Come on

Up up and away!

Mental, beat last year's high

Are tightly held

9p paid

Watch

Fly up 200%

Probably go flying up on sentiment alone

So much to come Check out the companies they have invested in Paraytec Kirkstall Gyrometric Pyreos

Here